MGNI Refresh: The Balance Sheet Got Better by Looking Worse

Magnite's cash balance fell from $553M to $185M last quarter. If you screen on cash, that looks like a company in trouble. It's the opposite — and it's a good excuse to write about why I run every name through the same framework instead of reacting to headline numbers.

This is a refresh of an existing holding, so the question isn't "should I buy" — it's "did anything break, and is the price still inside the fair value range?"

As always: FACTS come from primary sources (SEC filings, the company's own releases), cited inline. REASONING is my interpretation. The two never mix. Nothing here is investment advice; I hold MGNI.

What actually happened to the cash

FACTS. Per the Q1 2026 10-Q, Magnite repaid $205M of convertible notes during the quarter. Long-term debt dropped from ~$556M to ~$351M. Cash ended at $184.6M. Q1 also included $14.5M of buybacks and the usual seasonal working-capital outflow.

REASONING. The cash didn't leak — it retired debt. Net debt is now roughly $166M against $151.9M of FY2025 free cash flow (10-K: $236.2M operating cash flow minus $84.3M capex and capitalized software). That's under 1.1x net debt to FCF. This is the strongest the balance sheet has looked in the time I've held the name. A cash screen would have flagged this quarter as deterioration. The filings say deleveraging.

And yet — it still fails my balance sheet filter. Both versions.

This is the part I find genuinely interesting, and it's why I publish these.

My framework has a balance-sheet filter with two rules (a strict Graham-style one and a provisional looser one — long story, covered in previous posts). MGNI fails both:

FACTS (Q1 2026 10-Q, period ended 3/31/2026):

Current assets $1,647.6M vs current liabilities $1,620.9M → current ratio 1.02 (my threshold: >1.2)
TTM interest coverage: 3.53x (my threshold: >4x) — derived from TTM operating income of $106.7M against $30.2M of TTM interest expense
Current assets vs total liabilities ($2,028.6M): fails the strict rule too

REASONING. Both failures are structural artifacts, and both are worth understanding because they generalize.

The current ratio paradox. Magnite is a sell-side platform: it collects from ad buyers and remits to publishers. At quarter-end it was carrying $1.59B of payables (mostly owed to publishers) against $1.43B of receivables (owed by buyers). That's a working-capital conveyor belt, not a solvency problem. Any SSP — probably any ad intermediary — will structurally fail a current-ratio test regardless of how healthy it is. The ratio was designed for businesses that own inventory, not businesses that pass money through.

The trailing-coverage trap. TTM interest coverage charges Magnite twelve months of interest on debt that no longer exists. The $205M of converts was retired mid-window; quarterly interest expense is already down to $7.0M from $8.4M a year ago. The mechanical number says 3.53x. The forward run-rate will say something better — I'll recompute after Q2 prints.

Here's the discipline point: I log these as filter failures anyway. The rules don't get overridden in the moment, because in-the-moment overrides are how frameworks die. What happens instead is that both divergences go on the list for the next scheduled framework review, where I'll decide — calmly, away from any position — whether the rules need a pass-through adjustment or a pro-forma coverage clause. The filter governs new money; a held position with a documented divergence is a different situation than a new buy.

The quarter itself: the mix shift crossed a threshold

FACTS (Q1 2026 earnings release, 8-K Ex-99.1, May 6, 2026):

Revenue $164.4M, +6% YoY
Contribution ex-TAC $160.9M, +10% YoY
CTV contribution ex-TAC: $82.3M, +30% YoY — now over 50% of the total
DV+ (display and other): $78.6M, −5% YoY
Adjusted EBITDA $42.9M, 27% margin (25% a year ago)
Full-year guidance: ex-TAC growth ≥11% reaffirmed; Adjusted EBITDA margin raised to ≥35.5%; FCF growth guidance raised
GAAP net income positive in three of the last four quarters

REASONING. This quarter the thesis formally changed shape. The growing, defensible stream — CTV — is now the majority of the business. Magnite's position as the largest independent sell-side platform for streaming inventory carries real switching costs and a structural pitch to broadcasters who won't hand monetization to a competitor's ad stack. That stream grew 30%.

DV+, the open-web legacy business, is a melting cash cow: −5% and structurally pressured. But here's the arithmetic that matters — at current mix, CTV growing 30% absorbs DV+ declining 5% with room to spare. The thesis no longer needs DV+ to grow. It needs it to decline slowly. That's a much easier thing to be right about.

The honest threat inventory: Amazon and walled-garden encroachment in CTV are real and observable, not speculative. Large streamers building in-house is the credible bear mechanic. I apply the same rule to threats that I apply to upside: no unquantified scare stories, no unquantified optionality. At +30% growth, the observed evidence currently runs against the disintermediation story. That can change; it gets checked every quarter.

One accounting flag before valuation

FACTS. FY2025 net income was $144.6M (10-K). The FY2025 income tax line was a benefit of $74.0M, nearly all of it landing in Q4 — a deferred-tax valuation-allowance release.

REASONING. Roughly half of last year's "earnings" was a one-time accounting event, not operations. The headline trailing P/E of ~18x is flattered; on ex-benefit earnings it's closer to 35x. If you see MGNI on a value screen because of that P/E, the screen is lying to you. (Related flag: the company's self-reported "operating cash flow of $23.3M" for Q1 differs wildly from GAAP operating cash flow of −$120.8M for the same quarter — their metric excludes pass-through working-capital swings. Neither number is wrong; they measure different things. Know which one you're looking at.)

Valuation: three scenarios, each with a thesis

I don't do point estimates. Each case states what has to be true, shows its arithmetic from cited figures, and gets a rough weight. ~147M diluted shares throughout.

Bear (~25%): ~$12. CTV growth halves to ~15% as walled gardens take share, DV+ decline steepens to −10%, margin expansion stalls, FCF flat around $150M, and the market pays 12x FCF for a decelerating adtech. Confirming evidence would be two consecutive quarters of sub-20% CTV growth or DV+ guide cuts.

Base (~50%): ~$19.50. The company simply delivers its own guidance: ex-TAC +11%, ≥35.5% EBITDA margin, FCF growing to ~$170M. At 17x FCF that's ~$19.65/share; a 4.0x EV/revenue cross-check lands within pennies. When two methods converge, I trust the range more.

Bull (~25%): ~$27. CTV sustains 25–30% growth through 2027 — which is extrapolation of current economics, not a story about optionality — DV+ stabilizes, FY2027 FCF reaches ~$200M, and the market pays 20x for a majority-CTV platform with mid-teens growth and 35%+ margins.

Weighted fair value: ~$19.70. Range $12–27. Prior dossier had $16–21 with an $18.50 midpoint; the revision is modest and driven by the ex-TAC beat, the raised margin/FCF guidance, and the deleveraging.

Price as I write this: ~$20.36. The stock is at fair value. My framework requires a 25–35% discount to midpoint before adding to a mid-cap growth name — that's a buy trigger somewhere in the $13–15 zone, nowhere near current prices. And nothing broke, so there's nothing to sell. The tag stays OWN.

Sitting at fair value is also, for what it's worth, exactly the regime where writing covered calls against a held position makes sense — strikes above the fair value range convert "I'd be fine selling there" into premium. But that's a position-management topic, not a valuation one, and the option math never overrides the dossier tag.

The catalyst that quietly died

One more framework note, because this is the kind of thing a system catches and a vibe doesn't.

Part of the original thesis was the "$2B unlock" — sub-$2B companies are below many institutional mandates, and crossing that market cap mechanically expands the buyer base. Magnite is now a ~$2.9B company. That catalyst has fully fired. So has most of the profitability-inflection catalyst (GAAP-positive three of four quarters — the screens have found it).

Which means the position I hold today is not the position I bought. The entry thesis had mechanical catalysts; the current thesis is a pure fundamentals hold — CTV growth, margin expansion, FCF conversion. That's a legitimate thesis for this kind of name. But my framework has no explicit rule for re-underwriting a position whose entry catalyst has been consumed, and it should. Onto the review list it goes.

What I'm watching

Q2 earnings (early August — date not yet confirmed by the company): CTV within the $90–92M guide, DV+ slope, and the first clean interest-coverage read after the debt retirement.
Insider activity: a cluster of director sales in June/July all checked out as pre-scheduled 10b5-1 plan sales (verified against the Form 4 filings — plans adopted months earlier). One executive sale remains unverified; on the list.
The DV+ slope. −5% is fine. −15% is a different stock.

Long MGNI. Not investment advice — this is a public log of my own process, published mostly so future-me can't pretend he thought something different. All figures from SEC EDGAR (CIK 0001595974): FY2025 10-K, Q1 2026 10-Q, and the Q1 2026 earnings 8-K, except price quotes, which are from public quote services and timestamped in my private dossier.